When.com Web Search

Search results

  1. Results From The WOW.Com Content Network
  2. Clinical endpoint - Wikipedia

    en.wikipedia.org/wiki/Clinical_endpoint

    The primary endpoint of a clinical trial is the endpoint for which the trial is powered. Secondary endpoints are additional endpoints, preferably also pre-specified, for which the trial may not be powered.

  3. SCoRS - Wikipedia

    en.wikipedia.org/wiki/SCoRS

    The SCoRS is currently being used as a co-primary endpoint in several international phase 2 and phase 3 trials assessing cognitive treatment change in schizophrenia and has been permitted by the FDA for pivotal registration trials.

  4. Roche's Tecentriq Combo Study Meets Co-Primary Endpoint - AOL

    www.aol.com/news/roche-apos-tecentriq-combo...

    Roche's (RHHBY) phase III study, evaluating a combination of Tecentriq and Avastin plus carboplatin and paclitaxel for first line treatment of advanced lung cancer met its co-primary endpoint of ...

  5. FDA Approves LEQEMBI® (lecanemab-irmb) IV Maintenance Dosing ...

    lite.aol.com/tech/story/0022/20250126/9347687.htm

    In the Clarity AD core study (18 months), the mean change from baseline between the once every two weeks lecanemab treated group and the placebo group was -0.45 (P<0.0001) on the primary endpoint of the Clinical Dementia Rating-Sum of Boxes (CDR-SB) global cognitive and functional scale.

  6. Axsome Reveals Data From Alzheimer's Studies, Analyst ... - AOL

    www.aol.com/axsome-reveals-data-alzheimers...

    The ADVANCE-2 Phase 3 trial did not demonstrate statistical significance for the primary endpoint in delaying the time to relapse of agitation from baseline to Week 5, with reductions of 13.8 and ...

  7. Response evaluation criteria in solid tumors - Wikipedia

    en.wikipedia.org/wiki/Response_Evaluation...

    Only patients with measurable disease at baseline should be included in protocols where objective tumor response is the primary endpoint. Measurable disease – the presence of at least one measurable lesion. If the measurable disease is restricted to a solitary lesion, its neoplastic nature should be confirmed by cytology/histology.

  8. BioNTech's cancer drug meets primary endpoint in Phase 2 trial

    www.aol.com/news/biontechs-cancer-drug-meets...

    The trial met its primary endpoint, with data demonstrating a statistically significant improvement in the overall response rate in patients treated with the mRNA immunotherapy candidate BNT111 in ...

  9. Immutep Quarterly Activities Report Q2 FY25

    lite.aol.com/tech/story/0022/20250131/9350746.htm

    Phase II in soft tissue sarcoma shows three-fold increase in tumour hyalinization (trial’s primary endpoint, also associated with survival) compared to historical data from radiotherapy; Phase I trial of IMP761 reported favourable initial safety results advancing the first-in-class agonist LAG-3 antibody program